SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as the community debates the geopolitical and economic ramifications of a new memorandum of understanding between the U.S. and Iran. Discussions are heavily focused on the terms of the deal, the potential for market manipulation via official social media channels, and the broader concerns regarding current economic stability.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda to develop solid-state battery technology and manufacturing processes. Community sentiment is mixed as investors weigh the significance of a major OEM validation against the reality that the partnership focuses on research rather than immediate mass production.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The iShares 20+ Year Treasury Bond ETF (TLT) remains a focal point as traders react to persistent inflation concerns, the ongoing Iran-U.S. peace negotiations, and expectations surrounding the new Federal Reserve chair's potential policy direction. Community discourse is currently split between those anticipating a major bond market rally fueled by a potential end to geopolitical instability and others bracing for continued volatility as they monitor labor data and interest rate signals.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp is trending as investors weigh strong AI-driven infrastructure demand against sector-wide volatility triggered by semiconductor equipment peers. The community is actively discussing the company's role as an essential 'toll collector' in the chip manufacturing process while monitoring analyst price target adjustments and broader capital equipment cycles.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors react to strong quarterly growth and ongoing speculation regarding potential strategic interest or merger activity. The community is actively debating the company's valuation relative to its revenue expansion, the impact of pending litigation, and the significant institutional accumulation seen in recent filings.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors rotate into its QNX division, which is increasingly positioned as the critical safety-certified operating system for the emerging Physical AI and robotics sectors. The community is actively discussing recent analyst price target upgrades, positive institutional momentum, and the high-growth potential of the Alloy Kore platform ahead of upcoming earnings.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is seeing heightened investor attention following a combination of positive clinical data for its oncology portfolio and ongoing M&A speculation, including potential interest in selling its orthopedics unit to focus on high-growth assets. While the stock has attracted defensive capital, community sentiment remains split between excitement over the company's aggressive drug pipeline expansion and concerns regarding persistent talc-related litigation.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently facing intense bearish sentiment and significant volatility, with the community actively debating whether the token is at a generational bottom or suffering from terminal structural decay. Investors are focused on deep price corrections and the impact of broader market macro-trends, while some remain hopeful that the project's enterprise-grade technology and tokenization initiatives will lead to a long-term cyclical recovery.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is currently a major focus for investors as the escalating conflict in the Middle East and the closure of the Strait of Hormuz drive significant upside for domestic oil producers. Community sentiment remains highly bullish, with many traders emphasizing the stock's strong fundamentals and high free cash flow as key pillars to withstand the market volatility surrounding potential energy supply shocks.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased community interest driven by recent mentions in a Google research paper regarding quantum-resistant security and the network's post-quantum cryptography capabilities. While bulls are focused on accumulation and potential institutional adoption, others remain skeptical, engaging in ongoing debates about historical performance and price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CELC Stock Records Worst Day Ever After Late-Stage Breast Cancer Trial Results — What’s Driving The Selloff?

Equity

The company reported three deaths in the trial, though none were associated with its experimental drug gedatolisib.


What's Going On With Celcuity Stock On Tuesday?

Celcuity reported Phase 3 data showing gedatolisib improved progression-free survival in PIK3CA-mutated breast cancer.read more...

Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst

Celcuity expands VIKTORIA-2 to endocrine-sensitive breast cancer patients and advances injectable gedatolisib formulation.read more...

Celcuity (CELC) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Celcuity (CELC) to Release Earnings on Wednesday

Celcuity (NASDAQ:CELC) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 13. (View Earnings Report at...

Celcuity, Inc. (NASDAQ:CELC) Given Consensus Rating of "Moderate Buy" by Analysts

Celcuity, Inc. (NASDAQ:CELC - Get Free Report) has earned an average recommendation of "Moderate Buy" from the twelve ratings firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issu...

Best Biotech Stocks To Research - May 4th

Celcuity, Danaher, Vertex Pharmaceuticals, Rallybio, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies focused on developing biological products, drugs, diagnostics, or platform technologies...

Citizens Jmp Increases Celcuity (NASDAQ:CELC) Price Target to $160.00

Citizens Jmp increased their price target on shares of Celcuity from $150.00 to $160.00 and gave the stock a "market outperform" rating in a report on Monday...

Celcuity (NASDAQ:CELC) Reaches New 12-Month High on Analyst Upgrade

Celcuity (NASDAQ:CELC) Hits New 52-Week High on Analyst Upgrade...

"Just Another Dip Investors Will Buy": Futures Drop, Oil Rises On Renewed Iran Tension

"Just Another Dip Investors Will Buy": Futures Drop, Oil Rises On Renewed Iran Tension

 US futures whipsawed and crude oil spiked higher as tensions flared up again in the Middle East, taking the focus off a run of strong earnings by megacap tech companies. As of 8:00am ET, S&P and...

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$87.76
Prev Close	$88.05
Open	$88.17
Dividend Yield	0.00%
50-Day Moving Average	$118.04
Beta	1.08
Avg. Volume	1.26M
PE Ratio	-22.52

52-Week High	$151.02
52-Week Low	$11.28
Market Capitalization	$4.29B
EPS (Annual)	-$3.79
Price to Book	79.27
Revenue Per Employee	$0.00

CELCCelcuity Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CELC News